A detailed history of Tectonic Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tectonic Advisors LLC holds 29,921 shares of ABBV stock, worth $4.9 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
29,921
Previous 28,916 3.48%
Holding current value
$4.9 Million
Previous $4.48 Million 21.58%
% of portfolio
0.42%
Previous 0.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $160,619 - $183,010
1,005 Added 3.48%
29,921 $5.45 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $258,963 - $291,653
1,882 Added 6.96%
28,916 $4.48 Million
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $339,585 - $393,120
2,542 Added 10.38%
27,034 $4.03 Million
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $419,924 - $522,568
3,169 Added 14.86%
24,492 $3.3 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $606,928 - $698,968
4,197 Added 24.51%
21,323 $3.4 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $414,100 - $496,614
2,994 Added 21.19%
17,126 $2.77 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $376,727 - $432,081
2,807 Added 24.79%
14,132 $1.9 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $299,873 - $381,237
2,179 Added 23.82%
11,325 $1.73 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $153,228 - $190,113
1,161 Added 14.54%
9,146 $1.48 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $420,373 - $531,894
3,913 Added 96.1%
7,985 $1.08 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $122,572 - $139,138
1,152 Added 39.45%
4,072 $439,000
Q2 2021

Jul 22, 2021

BUY
$105.21 - $117.21 $49,238 - $54,854
468 Added 19.09%
2,920 $329,000
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $59,947 - $65,995
586 Added 31.4%
2,452 $266,000
Q4 2020

May 17, 2021

BUY
$80.49 - $108.67 $150,194 - $202,778
1,866 New
1,866 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tectonic Advisors LLC Portfolio

Follow Tectonic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.